Antithrombotic treatment after intracerebral haemorrhage

Luke A. Perry; Eivind Berge; Joshua Bowditch; Elisabeth Forfang; Ole Morten Rønning; Graeme J. Hankey; Elmer Villanueva; Rustam Al-Shahi Salman

doi:10.1002/14651858.CD012144

Antithrombotic treatment after intracerebral haemorrhage

Luke A. Perry^*
, Eivind Berge
, Joshua Bowditch
, Elisabeth Forfang
, Ole Morten Rønning
, Graeme J. Hankey
, Elmer Villanueva
, Rustam Al-Shahi Salman

^*Corresponding author for this work

Department of Health and Environmental Sciences

Research output: Contribution to journal › Review article › peer-review

26 Citations (Scopus)

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: Primary objective: To determine the effectiveness and safety of antithrombotic treatment in survivors of intracerebral haemorrhage (ICH). Secondary objective: To determine whether the effectiveness and safety of antithrombotic treatment differs in pre-specified subgroups (see Subgroup analysis and investigation of heterogeneity).

Original language	English
Article number	CD012144
Journal	Cochrane Database of Systematic Reviews
Volume	2016
Issue number	4
DOIs	https://doi.org/10.1002/14651858.CD012144
Publication status	Published - 8 Apr 2016

Access to Document

10.1002/14651858.CD012144

Cite this

@article{31972581d8f44166858ae114841c9eca,

title = "Antithrombotic treatment after intracerebral haemorrhage",

abstract = "This is the protocol for a review and there is no abstract. The objectives are as follows: Primary objective: To determine the effectiveness and safety of antithrombotic treatment in survivors of intracerebral haemorrhage (ICH). Secondary objective: To determine whether the effectiveness and safety of antithrombotic treatment differs in pre-specified subgroups (see Subgroup analysis and investigation of heterogeneity).",

author = "Perry, \{Luke A.\} and Eivind Berge and Joshua Bowditch and Elisabeth Forfang and R{\o}nning, \{Ole Morten\} and Hankey, \{Graeme J.\} and Elmer Villanueva and \{Al-Shahi Salman\}, Rustam",

note = "Publisher Copyright: {\textcopyright} 2016 The Cochrane Collaboration.",

year = "2016",

month = apr,

day = "8",

doi = "10.1002/14651858.CD012144",

language = "English",

volume = "2016",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

number = "4",

}

TY - JOUR

T1 - Antithrombotic treatment after intracerebral haemorrhage

AU - Perry, Luke A.

AU - Berge, Eivind

AU - Bowditch, Joshua

AU - Forfang, Elisabeth

AU - Rønning, Ole Morten

AU - Hankey, Graeme J.

AU - Villanueva, Elmer

AU - Al-Shahi Salman, Rustam

PY - 2016/4/8

Y1 - 2016/4/8

N2 - This is the protocol for a review and there is no abstract. The objectives are as follows: Primary objective: To determine the effectiveness and safety of antithrombotic treatment in survivors of intracerebral haemorrhage (ICH). Secondary objective: To determine whether the effectiveness and safety of antithrombotic treatment differs in pre-specified subgroups (see Subgroup analysis and investigation of heterogeneity).

AB - This is the protocol for a review and there is no abstract. The objectives are as follows: Primary objective: To determine the effectiveness and safety of antithrombotic treatment in survivors of intracerebral haemorrhage (ICH). Secondary objective: To determine whether the effectiveness and safety of antithrombotic treatment differs in pre-specified subgroups (see Subgroup analysis and investigation of heterogeneity).

UR - https://www.scopus.com/pages/publications/84962675684

U2 - 10.1002/14651858.CD012144

DO - 10.1002/14651858.CD012144

M3 - Review article

AN - SCOPUS:84962675684

SN - 1469-493X

VL - 2016

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 4

M1 - CD012144

ER -

Antithrombotic treatment after intracerebral haemorrhage

Abstract

Access to Document

Other files and links

Cite this